Groundbreaking Study: Ozempic and GLP-1 Drugs Shown to Reduce Risk of 42 Health Conditions
2025-01-20AOL
In a landmark study involving nearly 2 million patients, researchers have found that Ozempic and other GLP-1 receptor agonists significantly lower the risk of 42 health conditions, including heart attacks, Alzheimer's disease, and stroke. This extens ...Read more
Recommendations
Loading...